Javascript must be enabled to continue!
Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing
View through CrossRef
AbstractThe objective of our study was to compare Movement Disorder Society Task Force criteria for diagnosis of Parkinson's disease dementia (PDD) with the gold standard of traditional neuropsychological testing. A short checklist (Level I) and a protocol of neuropsychological tests (Level II) have been proposed by a Movement Disorder Society Task Force but not fully validated in clinical practice. Ninety‐one Parkinson's disease (PD) subjects were categorized as having dementia or no dementia based on a battery of neuropsychological test results and clinical judgment. The isolated components needed for Level I and Level II diagnoses were then culled from the neuropsychological evaluations and independently used to designate PDD. Compared with traditional neuropsychological testing, the sensitivity and specificity of Level I criteria for PDD was 66.7% and 98.8%, and for Level II criteria 100% and 92.7%, respectively. Using Level II criteria, 6 additional subjects were diagnosed with PDD that were classified as having no dementia when full neuropsychological data were used for the diagnosis. These 6 subjects had more education years and were less impaired on cognitive tests. The Movement Disorder Society's Level II criteria more frequently classify subjects with PDD than does traditional neuropsychological testing. Whereas Level II criteria may overclassify subjects as having PDD, they are very accurate in ruling out dementia. Movement Disorder Society's criteria are practical and timesaving, although full neuropsychological testing may still be needed. © 2014 International Parkinson and Movement Disorder Society
Title: Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing
Description:
AbstractThe objective of our study was to compare Movement Disorder Society Task Force criteria for diagnosis of Parkinson's disease dementia (PDD) with the gold standard of traditional neuropsychological testing.
A short checklist (Level I) and a protocol of neuropsychological tests (Level II) have been proposed by a Movement Disorder Society Task Force but not fully validated in clinical practice.
Ninety‐one Parkinson's disease (PD) subjects were categorized as having dementia or no dementia based on a battery of neuropsychological test results and clinical judgment.
The isolated components needed for Level I and Level II diagnoses were then culled from the neuropsychological evaluations and independently used to designate PDD.
Compared with traditional neuropsychological testing, the sensitivity and specificity of Level I criteria for PDD was 66.
7% and 98.
8%, and for Level II criteria 100% and 92.
7%, respectively.
Using Level II criteria, 6 additional subjects were diagnosed with PDD that were classified as having no dementia when full neuropsychological data were used for the diagnosis.
These 6 subjects had more education years and were less impaired on cognitive tests.
The Movement Disorder Society's Level II criteria more frequently classify subjects with PDD than does traditional neuropsychological testing.
Whereas Level II criteria may overclassify subjects as having PDD, they are very accurate in ruling out dementia.
Movement Disorder Society's criteria are practical and timesaving, although full neuropsychological testing may still be needed.
© 2014 International Parkinson and Movement Disorder Society.
Related Results
Understanding the knowledge and attitudes to dementia in Sub‐Saharan Africa: A systematic review
Understanding the knowledge and attitudes to dementia in Sub‐Saharan Africa: A systematic review
AbstractBackgroundA direct result of an ageing population is an increase in the prevalence of chronic non‐communicable diseases such as dementia. Creating dementia awareness and pr...
Memory and executive function impairment predict dementia in Parkinson's disease
Memory and executive function impairment predict dementia in Parkinson's disease
AbstractWe analyzed the association of neuropsychological test impairment at baseline with the development of dementia in idiopathic Parkinson's disease (PD) patients. A cohort of ...
Leveraging Clinical Notes and Natural Language Processing for Dementia Detection (Preprint)
Leveraging Clinical Notes and Natural Language Processing for Dementia Detection (Preprint)
BACKGROUND
Routinely collected data (e.g. coded hospital data, clinical notes) are widely being used to develop dementia prevalence estimates. This is limit...
Dementia Subtypes: A Study From Dementia Clinic In A Referral Neuroscience Hospital, Bangladesh
Dementia Subtypes: A Study From Dementia Clinic In A Referral Neuroscience Hospital, Bangladesh
Background: Dementia is one of the major causes of disability and dependency among older people globally but still it is not explored very well in most parts of the world particula...
ENGAGE-DEM : a model of engagement of people with dementia
ENGAGE-DEM : a model of engagement of people with dementia
Dementia is a neurodegenerative disease that affects cognition, producing a reduction in thinking, problem-solving, and mnemonic abilities, functioning, preventing affected people ...
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Abstract
Pharmacotherapy of dementia is a critical intervention for managing symptoms of and slowing progression of dementia. However, evidence on prescribing patter...
Translating ‘dementia friends’ programme to undergraduate medical and nursing practice: a qualitative exploration
Translating ‘dementia friends’ programme to undergraduate medical and nursing practice: a qualitative exploration
Abstract
Introduction
Dementia awareness is a key priority of medical and nursing pre-registration education. The ‘dementia friends’ programme is an...
Clinical validation of movement disorder society–recommended diagnostic criteria for Parkinson's disease with dementia
Clinical validation of movement disorder society–recommended diagnostic criteria for Parkinson's disease with dementia
AbstractThe objective of this work was to evaluate the Movement Disorders Society (MDS) Task Force–proposed screening checklist for detecting Parkinson's disease dementia (PD‐D) in...

